HILLEVAX INC (HLVX) Stock Overview
NASDAQ:HLVX - US43157M1027 - Common Stock
HLVX Key Statistics, Chart & Performance
The current stock price of HLVX is 2.09 USD. In the past month the price increased by 2.45%. In the past year, price increased by 11.76%.
HLVX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.68B | ||
| AMGN | AMGEN INC | 13.19 | 154.89B | ||
| GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
| INSM | INSMED INC | N/A | 28.77B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
| NTRA | NATERA INC | N/A | 23.09B | ||
| BIIB | BIOGEN INC | 8.26 | 19.38B |
Related stock screener links
About HLVX
Company Profile
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. The company is headquartered in Boston, Massachusetts and currently employs 14 full-time employees. The company went IPO on 2022-04-29. The firm's programs, HIL-214 and HIL-216, are virus-like particle (VLP) based vaccine candidates in development for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. HIL-214 consists of VLPs which are designed to mimic the structure of norovirus and are co-formulated with an alum adjuvant to enhance immunogenicity and stability of the VLPs in solution. HIL-214 is administered intramuscularly via prefilled syringes and has demonstrated stability at standard refrigeration temperatures of four degrees Celsius for 24 months. The firm has in-licensed HIL-216 from Chengdu Kanghua Biological Products Co., Ltd. (Kangh), a Chinese company. Its license provides world-wide rights to the vaccine outside of the Chinese market. HIL-216 includes six common norovirus genotypes: GI.1, GII.2, GII.3, GII.4, GII.6 and GII.17.
Company Info
HILLEVAX INC
321 Harrison Ave, Suite 500
Boston MASSACHUSETTS US
Employees: 14
Phone: 16172135054
HILLEVAX INC / HLVX FAQ
What is the stock price of HILLEVAX INC today?
The current stock price of HLVX is 2.09 USD. The price increased by 0.48% in the last trading session.
What is the ticker symbol for HILLEVAX INC stock?
The exchange symbol of HILLEVAX INC is HLVX and it is listed on the Nasdaq exchange.
On which exchange is HLVX stock listed?
HLVX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HILLEVAX INC stock?
7 analysts have analysed HLVX and the average price target is 2.04 USD. This implies a price decrease of -2.39% is expected in the next year compared to the current price of 2.09. Check the HILLEVAX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HILLEVAX INC worth?
HILLEVAX INC (HLVX) has a market capitalization of 104.79M USD. This makes HLVX a Micro Cap stock.
How many employees does HILLEVAX INC have?
HILLEVAX INC (HLVX) currently has 14 employees.
What are the support and resistance levels for HILLEVAX INC (HLVX) stock?
HILLEVAX INC (HLVX) has a support level at 2.08 and a resistance level at 2.14. Check the full technical report for a detailed analysis of HLVX support and resistance levels.
Should I buy HILLEVAX INC (HLVX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HLVX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HLVX, evaluating the profitability, health, valuation and growth aspects
- HILLEVAX INC (HLVX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HILLEVAX INC (HLVX) Sales and EPS estimates to see what analysts future expectations are.
- HILLEVAX INC (HLVX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HILLEVAX INC (HLVX) Insider and Institutional Ownership to learn about the owners and their transactions.
- HILLEVAX INC (HLVX) Stock Chart to make your own analysis
- HILLEVAX INC (HLVX) Latest news and press-releases to stay up to date.
Does HILLEVAX INC (HLVX) stock pay dividends?
HLVX does not pay a dividend.
What is the Price/Earnings (PE) ratio of HILLEVAX INC (HLVX)?
HILLEVAX INC (HLVX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.43).
What is the Short Interest ratio of HILLEVAX INC (HLVX) stock?
The outstanding short interest for HILLEVAX INC (HLVX) is 1.47% of its float. Check the ownership tab for more information on the HLVX short interest.
HLVX Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to HLVX. When comparing the yearly performance of all stocks, HLVX turns out to be only a medium performer in the overall market: it outperformed 69.76% of all stocks.
HLVX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HLVX. While HLVX has a great health rating, there are worries on its profitability.
HLVX Financial Highlights
Over the last trailing twelve months HLVX reported a non-GAAP Earnings per Share(EPS) of -1.43. The EPS increased by 57.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -40.65% | ||
| ROE | -48.1% | ||
| Debt/Equity | 0 |
HLVX Forecast & Estimates
7 analysts have analysed HLVX and the average price target is 2.04 USD. This implies a price decrease of -2.39% is expected in the next year compared to the current price of 2.09.